Reducing Activities: company scaling back some business operations while continuing others
Stay Scaling Back
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim is a German pharmaceutical company.
Reducing Activities: company scaling back some business operations while continuing others
Stay Scaling BackRevenue(RF), mln.USD
404
Assets(RF), mln.USD
125
Capital(RF), mln.USD
50
Glob.Revenue, mln.USD
21778
Staff(RF), 2021
2546
The Company Statement
Scale back to just supplying medicine. The media learned about the supply of veterinary drugs to Russia through “unofficial channels”.
| March 27, 2024 | Russia was left without imported drugs to treat animals |
| November 22, 2023 | The media learned about the supply of veterinary drugs to Russia through “unofficial channels” |
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner